|
S. No.
|
Molecules |
Therapeutic indications |
|
1. |
Human insulin |
Diabetes |
|
2. |
Erythropoietin |
Anemia |
|
3. |
Hepatitis B vaccine (recombinant surface antigen based) |
Hepatitis B |
|
4. |
Human growth hormone |
Deficiency of growth hormone in children |
|
5. |
Interleukin 2 |
Renal cell carcinoma |
|
6. |
Interleukin 11 |
Thrombocytopenia |
|
7. |
Granulocyte Colony Stimulating Factor (GCSF) |
Chemotherapy induced neutropenia |
|
8. |
Granulocyte Macrophage Colony Stimulating Factor (GMCSF) |
Chemotherapy induced neutropenia |
|
9. |
Interferon-2a |
Chronic myeloid leukemia |
|
10. |
Interferon-2b |
Chronic myeloid leukemia, Hepatitis B and Hepatitis C |
|
11. |
Interferon-g |
Chronic granulomatous disease and severe malignant
osteopetrosis |
|
12. |
Streptokinase |
Acute myocardial infarction |
|
13. |
Tissue Plasminogen Activator |
Acute myocardial infarction |
|
14. |
Blood factor VIII |
Haemophilia type A |
|
15. |
Follicle stimulating hormone |
Reproductive disorders |
|
16. |
Teriparatide (Forteo) |
Osteoporosis |
|
17. |
Drotrecogin (Xigris) alpha. |
Severe sepsis |
|
18. |
Platelet Derived Growth Factor (PDGF) |
Bone marrow induction and osteoblasts proliferation |
|
19. |
Epidermal Growth factor (EGF) |
Mitogenesis and organ morphogenesis |
|
20. |
Eptacogalpha (r-F VIIa) r-coagulation factor |
Haemorrhages, congenital
or acquired hemophilia |